Medical Tubing Industry Sees Strong Recovery, Finds Marketsandmarkets™

By Author: Jack Martin
Total Articles: 256
Comment this article

In the global medical tubing industry size is estimated at USD 4.9 billion in 2021 and is projected to reach USD 7.9 billion by 2026, at a CAGR of 10.0%. The demand for medical tubing is primarily driven by the increase in aging population, shift toward minimally invasive medical procedures, and increasing demand for medical devices that incorporate tubing. However, stringent and time-consuming regulatory policies is a key challenge faced by manufacturers of medical tubing.

Request a Sample of this Report@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162082103

The APAC region is expected to be the fastest-growing medical tubing market during the forecast period. In terms of value. APAC is projected to register the highest growth during the forecast period. The growth in this region can be attributed to the improving lifestyle of the population, increasing purchasing power of consumers, rising economic growth in many countries, and increased spending by governments of various countries on healthcare services. Japan is a significant manufacturer of medical devices and shows high demand for medical ...
... tubing. Medical device manufacturing is also growing in China due to government initiatives to improve the healthcare conditions in the country, thus boosting the demand for medical tubing. Europe and North America are relatively mature markets compared to South America and the Middle East & Africa.

Based on material, the specialty polymers segment is projected to grow at the highest CAGR during the forecast period. Some specialty polymers used in medical tubing are bioabsorbable polymer and ethylene vinyl acetate. Bioabsorbable materials are manufactured in a controlled environment and packaged with high barrier flexible material for the healthcare market. Bioabsorbable polymers are chemical compound used in implant devices which eventually dissolves and is absorbed by the body. They are suitable materials for the prosthetic as they can be engineered to dissolve at the same rate as bone growth. These materials are also durable and elastic. Polyglycolic acid (PGA) and polylactic acid (PLA) are bioabsorbable polymers used for medical tubing.

Get Customization on this Research Report for Specific Research Solutions@ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162082103

Based on application, the drug delivery system application segment is projected to grow at the highest CAGR between 2021 and 2026. Drug delivery is a method or approach used to deliver drugs or medications to achieve a therapeutic effect in humans or animals. Drug delivery can be used for the treatment or diagnosis of numerous diseases, such as diabetes, kidney failure, heart diseases, and others. Medical tubing is used as a device or channel of delivery in drug delivery systems. Nasogastric tubes are used for enteral feeding and drainage. PU or silicone tubes are generally used for this because as they are unaffected by gastric acid and can, therefore, remain in the stomach for a longer period compared to PVC tubing.

The key players in this market are Saint-Gobain (France), Freudenberg Medical LLC. (US), W.L. Gore and Associates Inc. (US), Avient Corporation (US), Raumedic AG (Germany), Lubrizol Corporation (US), Elkem ASA (Norway), Dow Corning Corporation (US), Nordson Corporation (US), Teknor Apex (US), and Optinova (Finland). These players have adopted various strategies such as investment & expansion, merger & acquisition, partnership & agreement, and new product launch in order to strengthen their market position. For instance, in August 2021, Nordson Corporation entered into a distribution agreement with Qosina. Under this agreement, the company will distribute its medical products through its distribution partner, Qosina.

If You Want To Know More About Report Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162082103

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441